Becaplermin

Becaplermin Struktur
165101-51-9
CAS-Nr.
165101-51-9
Englisch Name:
Becaplermin
Synonyma:
Regranex;RWJ 60235;Becaplermin
CBNumber:
CB81402016
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Becaplermin Eigenschaften

Sicherheit

Becaplermin Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Chronic dermal ulcers treatment (promotes the proliferation of mesenchymally-derived cells).

Indications

Becaplermin (Regranex) is a recombinant human platelet–derived growth factor (rhPDGF-BB) which is thought to enhance wound healing by stimulating granulation tissue. It is approved for the treatment of lower extremity neuropathic ulcers extending to the subcutaneous tissue in diabetic patients with an adequate blood supply. Local irritant reactions (erythema, burning, pain) occur in a minority of patients.

Clinical Use

Becaplermin, Regranex Gel, an endogenous polypeptidethat is released from cells that are involved in the healingprocess, is a recombinant human platelet–derived growthfactor (rhPDGF-BB). It is a growth factor that activates cell proliferation,differentiation, and function, and it is released from cells involvedin the healing process.Becaplermin is formulated as a gel recommended fortopical use in the treatment of ulcerations of the skin secondaryto diabetes.

Becaplermin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Becaplermin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Beijing HuaMeiHuLiBiological Chemical 010-56205725
waley188@sohu.com China 12323 58
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105
2881489226@qq.com China 89667 60

165101-51-9()Verwandte Suche:


  • Becaplermin
  • RWJ 60235
  • Regranex
  • 165101-51-9
Copyright 2019 © ChemicalBook. All rights reserved